Updated guidelines for prescribing opioids to treat patients with chronic non-cancer pain in Korea: developed by committee on hospice and palliative care of the Korean Pain Society

키워드

참고문헌 (49)

1. Manchikanti L, "Responsible, safe, and effective prescription of opioids for chronic noncancer pain : American Society of Interventional Pain Physicians(ASIPP)guidelines", Pain Physician, 20, pp.S3~S92 (2017)
2. Häuser W, "European* clinical practice recommendations on opioids for chronic noncancer pain-Part 1 : role of opioids in the management of chronic noncancer pain", Eur J Pain, 25, pp.949~968 (2021)
3. Oh TK, "Trends in chronic opioid use and association with five-year survival in South Korea : a population-based cohort study", Br J Anaesth, 123, pp.655~663 (2019)
4. Noh Y, "Trends in potentially inappropriate opioid prescribing and associated risk factors among Korean noncancer patients prescribed non-injectable opioid analgesics", Ther Adv Drug Saf, 13, pp.20420986221091001~ (2022)
5. Porter J, "Addiction rare in patients treated with narcotics", N Engl J Med, 302, pp.123~ (1980)
6. Rummans TA, "How good intentions contributed to bad outcomes : the opioid crisis", Mayo Clin Proc, 93, pp.344~350 (2018)
7. Yang J, "The modified WHO analgesic ladder : is it appropriate for chronic non-cancer pain", J Pain Res, 13, pp.411~417 (2020)
8. Kim ED, "Guidelines for prescribing opioids for chronic non-cancer pain in Korea", Korean J Pain, 30, pp.18~33 (2017)
9. Dowell D, "CDC clinical practice guideline for prescribing opioids for pain-United States, 2022", MMWR Recomm Rep, 71, pp.1~95 (2022)
10. Turk DC, "Bonica's management of pain", pp.313~324 (2019), Wolters Kluwer
11. Kim S, "Cost-effectiveness of an opioid abuse-prevention program using the narcotics information management system in South Korea", Value Health, 24, pp.174~181 (2021)
12. Lee J, "Evaluation of preventable adverse drug reactions by implementation of the nationwide network of prospective drug utilization review program in Korea", PLoS One, 13, pp.e0195434~ (2018)
13. Busse JW, "Management of acute pain from nonlow back, musculoskeletal injuries : a systematic review and network meta-analysis of randomized trials", Ann Intern Med, 173, pp.730~738 (2020)
14. Krebs EE, "Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain : the SPACE randomized clinical trial", JAMA, 319, pp.872~882 (2018)
15. "Neuropathic pain in adults: pharmacological management in non-specialist settings" (2020)[URL]
16. Busse JW, "Guideline for opioid therapy and chronic noncancer pain", CMAJ, 189, pp.E659~E666 (2017)
17. "Opioid treatments for chronic pain" (2020)[URL]
18. Miller M, "Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy", JAMA Intern Med, 175, pp.608~615 (2015)
19. Krčevski Škvarč N, "European clinical practice recommendations on opioids for chronic noncancer pain-Part 2 : special situations", Eur J Pain, 25, pp.969~985 (2021)
20. Chou R, "The effectiveness and risks of long-term opioid treatment of chronic pain", Evid Rep Technol Assess (Full Rep), 218, pp.1~219 (2014)
21. Moisset X, "Opioid use for the management of chronic non-cancer pain : French guidelines", Rev Neurol (Paris), 172, pp.337~338 (2016)
22. Kalso E, "Predicting long-term response to strong opioids in patients with low back pain : findings from a randomized, controlled trial of transdermal fentanyl and morphine", BMC Med, 5, pp.39~ (2007)
23. Hasin DS, "DSM-5 criteria for substance use disorders : recommendations and rationale", Am J Psychiatry, 170, pp.834~851 (2013)
24. O'Brien CP, "What's in a word? Addiction versus dependence in DSM-V", Am J Psychiatry, 163, pp.764~765 (2006)
25. "Prescribing policies: states confront opioid overdose epidemic" (2020)[URL]
26. Shah A, "Characteristics of initial prescription episodes and likelihood of longterm opioid use-United States, 2006-2015", MMWR Morb Mortal Wkly Rep, 66, pp.265~269 (2017)
27. Brummett CM, "New persistent opioid use after minor and major surgical procedures in US adults", JAMA Surg, 152, pp.e170504~ (2017)
28. Mundkur ML, "Days' supply of initial opioid analgesic prescriptions and additional fills for acute pain conditions treated in the primary care setting-United States, 2014", MMWR Morb Mortal Wkly Rep, 68, pp.140~143 (2019)
29. Treatments for acute pain: a systematic review, "Chou R", Agency for Healthcare Research and Quality (US), ~, pp.20(21)-EHC006 (2020)
30. Edlund MJ, "The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain : the role of opioid prescription", Clin J Pain, 30, pp.557~564 (2014)
31. Oliva EM, "Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans : observational evaluation", BMJ, 368, pp.m283~ (2020)
32. Rich RC, "Best practices, research gaps, and future priorities to support tapering patients on long-term opioid therapy for chronic non-cancer pain in outpatient settings", NAM Perspect, 2020 (2020)[DOI]
33. "Safety Announcement. FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering" (2019)[URL]
34. Mark TL, "Opioid medication discontinuation and risk of adverse opioid-related health care events", J Subst Abuse Treat, 103, pp.58~63 (2019)
35. Dowell D, "Patient-centered reduction or discontinuation of long-term opioid analgesics : the HHS guide for clinicians", JAMA, 322, pp.1855~1856 (2019)
36. Joo SS, "Implementation of a patientspecific tapering protocol at discharge decreases total opioid dose prescribed for 6 weeks after elective primary spine surgery", Reg Anesth Pain Med, 45, pp.474~478 (2020)
37. Tamboli M, "A multidisciplinary patient-specific opioid prescribing and tapering protocol is associated with a decrease in total opioid dose prescribed for six weeks after total hip arthroplasty", Pain Med, 21, pp.1474~1481 (2020)
38. Swarm RA, "Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology", J Natl Compr Canc Netw, 17, pp.977~1007 (2019)
39. Nielsen S, "A synthesis of oral morphine equivalents(OME)for opioid utilisation studies", Pharmacoepidemiol Drug Saf, 25, pp.733~737 (2016)
40. Voon P, "Chronic pain and opioid misuse : a review of reviews", Subst Abuse Treat Prev Policy, 12, pp.36~ (2017)
41. Savage SR, "Definitions related to the medical use of opioids : evolution towards universal agreement", J Pain Symptom Manage, 26, pp.655~667 (2003)
42. Kosten TR, "Substance-use disorders in DSM-III-R. Evidence for the dependence syndrome across different psychoactive substances", Br J Psychiatry, 151, pp.834~843 (1987)
43. Fainsinger RL, "What's in a word? Addiction versus dependence in DSM-V", Am J Psychiatry, 163, pp.2014~ (2006)
44. Miller SC, "Language and addiction", Am J Psychiatry, 163, pp.2015~ (2006)
45. Streltzer J, "Addiction versus dependence in pain management", Am J Psychiatry, 163, pp.2016~ (2006)
46. O'Brien C, "Addiction and dependence in DSM-V", Addiction, 106, pp.866~867 (2011)
47. Ballantyne JC, "Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain", Pain, 156, pp.567~568 (2015)
48. Ballantyne JC, "Opioid dependence vs addiction : a distinction without a difference", Arch Intern Med, 172, pp.1342~1343 (2012)
49. Kosten TR, "Review article : effective management of opioid withdrawal symptoms : a gateway to opioid dependence treatment", Am J Addict, 28, pp.55~62 (2019)

관련 논문AI추천